GENNEX LABORATORIES
Back to Cashflow Statement
|
GENNEX LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹74 Cr | ₹21 Cr | ₹-1.83 Cr | ₹1.62 Cr | ₹-0.35 Cr |
What is the latest Cash Flow from Financing Activities ratio of GENNEX LABORATORIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹74 Cr |
Mar2023 | ₹21 Cr |
Mar2022 | ₹-1.83 Cr |
Mar2021 | ₹1.62 Cr |
Mar2020 | ₹-0.35 Cr |
How is Cash Flow from Financing Activities of GENNEX LABORATORIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹74 Cr | 250.33 | |
Mar2023 | ₹21 Cr | Positive | |
Mar2022 | ₹-1.83 Cr | Negative | |
Mar2021 | ₹1.62 Cr | Positive | |
Mar2020 | ₹-0.35 Cr | - |
Compare Cash Flow from Financing Activities of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹317.0 Cr | 1.4% | -15.6% | -34.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | 1.4% |
-15.6% |
-34.7% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses